Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolic Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05554822
What this trial is testing

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

Who this might be right for
Left Atrial Appendage OcclusionAntiplatelet Therapy
Azienda Ospedaliero Universitaria Maggiore della Carita 574
Large-scale testing (Phase 3)Not Yet RecruitingNCT07821008
What this trial is testing

TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study

Who this might be right for
Subarachnoid Hemorrhage, AneurysmalBrain IschemiaEndovascular Procedure
University Hospital, Toulouse 274
Very early researchLooking for participantsNCT06615596
What this trial is testing

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases 3,160
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726
What this trial is testing

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Les Laboratoires des Médicaments Stériles 120
Large-scale testing (Phase 3)UnknownNCT02313584
What this trial is testing

Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

Who this might be right for
Atrial FibrillationThromboembolism
Korea University 464
Not applicableStudy completedNCT04414332
What this trial is testing

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry

Who this might be right for
Venous Thromboembolic DiseaseDeep Venous ThrombosisRight Heart Pathology+1 more
University of California, Los Angeles 234
Not applicableEnded earlyNCT04199793
What this trial is testing

Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

Who this might be right for
ThromboembolismHemolysisStroke
Vanderbilt University Medical Center 9
Not applicableLooking for participantsNCT02741349
What this trial is testing

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Saint Antoine University Hospital 825
Not applicableLooking for participantsNCT04628078
What this trial is testing

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Who this might be right for
Atrial FibrillationCardiovascular DiseasesThromboembolism
Insel Gruppe AG, University Hospital Bern 1,000
Not applicableStudy completedNCT01102933
What this trial is testing

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients

Who this might be right for
Myocardial Infarction
Uppsala University 425
Testing effectiveness (Phase 2)Looking for participantsNCT06038630
What this trial is testing

129Xe MRI Cardiopulmonary

Who this might be right for
Interstitial Lung DiseaseChronic Thromboembolic Pulmonary HypertensionAcute Pulmonary Embolism+3 more
Bastiaan Driehuys 125
Not applicableStudy completedNCT03786367
What this trial is testing

Dyspnea in Chronic Thromboembolic Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Dr. Denis O'Donnell 28
Post-approval studies (Phase 4)Ended earlyNCT00528671
What this trial is testing

Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications

Who this might be right for
Mechanical Heart Valve Recipients
Heart and Diabetes Center North-Rhine Westfalia 1,571
Not applicableStudy completedNCT04472533
What this trial is testing

Serum Bio-markers in Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension, Primary, 4
Papworth Hospital NHS Foundation Trust 377
Testing effectiveness (Phase 2)WithdrawnNCT03398434
What this trial is testing

Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT00580216
What this trial is testing

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sanofi 3,773
Not applicableUnknownNCT06003244
What this trial is testing

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Who this might be right for
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
University of Zurich 24
Not applicableLooking for participantsNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Testing effectiveness (Phase 2)Study completedNCT04850378
What this trial is testing

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeThromboembolic Disease
University of Aarhus 57
Not applicableStudy completedNCT03015025
What this trial is testing

Pharmacogenetic Dosage Algorithm for Acenocoumarol

Who this might be right for
Atrial FibrillationVenous ThrombosesCardiac Valve Disease
Instituto de Investigación Hospital Universitario La Paz 340
Next Page